TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Viemed Healthcare ( (VMD) ) is now available.
Viemed Healthcare has completed its acquisition of Lehan’s Medical Equipment for $26 million, with additional contingent payments. This acquisition is expected to enhance Viemed’s market presence by combining Lehan’s established brand and expertise with Viemed’s national scale and care delivery model. The acquisition is anticipated to contribute to Viemed’s financial performance, with an update to its 2025 financial outlook expected following the integration of Lehan’s operations.
The most recent analyst rating on (VMD) stock is a Buy with a $15.00 price target. To see the full list of analyst forecasts on Viemed Healthcare stock, see the VMD Stock Forecast page.
Spark’s Take on VMD Stock
According to Spark, TipRanks’ AI Analyst, VMD is a Outperform.
Viemed Healthcare’s strong financial performance, strategic acquisitions, and positive earnings outlook contribute significantly to its stock appeal. While technical analysis shows mixed signals, the company’s robust growth strategy and recent corporate actions reinforce its potential.
To see Spark’s full report on VMD stock, click here.
More about Viemed Healthcare
Viemed Healthcare, Inc. is an in-home clinical care provider specializing in post-acute respiratory healthcare equipment and services in the United States. The company offers non-invasive ventilators, sleep therapy, staffing, and other complementary products and services, focusing on efficient in-home treatment with clinical practitioners providing therapy, education, and counseling.
Average Trading Volume: 182,867
Technical Sentiment Signal: Sell
Current Market Cap: $276.7M
See more data about VMD stock on TipRanks’ Stock Analysis page.